Clinical Trial Details

Trial ID: L0699
Source ID: IRCT138902253933N1
Associated Drug: Silymarin
Title: To Survey effect of Selimarine, Vit E, and Metformine in nonalcoholic fatty liver patients
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic Fatty liver. <br>Diseases of the digestive system;K71, K72, ;Diseases of the digestive system
Interventions: Intervention 1: Metformine (oral tablet, 500mg twice daily for 2 months). Intervention 2: Silymarin (oral tablet, 70 mg daily for 2 months). Intervention 3: Vit E (oral tablet, 400 mg daily for 2 months).;Treatment - Drugs;Treatment - Drugs;Treatment - Dr
Outcome Measures: Serum levels of liver enzymes. Timepoint: before intervention, 2 months after intervention. Method of measurement: Counter.nan
Sponsor/Collaborators: Kermanshah University of Medical Sciences
Gender: All
Age: no limitno limit
Phases: Not applicable
Enrollment: 135
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 01/01/1900
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/4120